Renhe Pharmacy Co.,Ltd (SHE:000650)
China flag China · Delayed Price · Currency is CNY
4.890
-0.059 (-1.20%)
Nov 13, 2026, 3:04 PM CST

Renhe Pharmacy Co.,Ltd Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
386.24393.21481.91567.26574.43665.02
Depreciation & Amortization
115.25115.25122.65141.7117.1586.64
Other Amortization
3.973.972.845.456.585.5
Loss (Gain) From Sale of Assets
-2.05-2.05-1.370.27-0.34-16.84
Asset Writedown & Restructuring Costs
119.52119.52105.01207.6332.421.44
Loss (Gain) From Sale of Investments
-108.55-108.55-88.74-76.09-68.43-31.45
Provision & Write-off of Bad Debts
32.5432.5428.613.926.672.42
Other Operating Activities
-310.9104.693.2180.17173.97140.89
Change in Accounts Receivable
178.96178.96149.68-118.15127.1-62.47
Change in Inventory
-49.23-49.237.719.78111.63-124.42
Change in Accounts Payable
78.3178.31-353.64-313.28182.28101.35
Change in Other Net Operating Assets
-15.53-15.5315.53-17.3210.39
Operating Cash Flow
428.85851.31557.26499.471,270777.72
Operating Cash Flow Growth
-60.99%52.77%11.57%-60.67%63.30%-12.30%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-47.84-74.59-285.72-186.55-221.09-499.78
Sale of Property, Plant & Equipment
0.150.368.952.020.2922.63
Cash Acquisitions
0.03-0.06----704.65
Divestitures
----15.78-
Investment in Securities
-99.2-138.41-268.3-187.49-413.661,472
Other Investing Activities
106.69114.4182.6377.9743.5228.93
Investing Cash Flow
-40.18-98.29-462.44-294.04-575.17319.26

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Repaid
------60
Long-Term Debt Repaid
--0.79-5.89-7.07-5.55-3.55
Lease Payments
-0.79-0.79-5.89-7.07-5.55-3.55
Total Debt Repaid
-0.79-0.79-5.89-7.07-5.55-63.55
Net Debt Issued (Repaid)
-0.79-0.79-5.89-7.07-5.55-63.55
Issuance of Common Stock
2.332.33---139.75
Repurchase of Common Stock
---39.93-60.08--199.64
Common Dividends Paid
-210.48-210.48-279.93-279.42-140.17-283.22
Other Financing Activities
-167.08-95.67-58.03-69.49-84.36-55.53
Financing Cash Flow
-376.03-304.62-383.78-416.06-230.08-462.19

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.06-0.01---0-0
Net Cash Flow
12.58448.4-288.96-210.63464.74634.79

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
381.01776.72271.54312.921,049277.93
Free Cash Flow Growth
-61.71%186.04%-13.22%-70.17%277.39%-58.25%
Free Cash Flow Margin
10.90%21.96%6.66%6.22%20.35%5.63%
Free Cash Flow Per Share
0.270.550.200.220.750.20
Levered Free Cash Flow
284.52671.27125.8136.97892.17211.09
Unlevered Free Cash Flow
284.57671.32125.9137.18892.43211.7
Free Cash Flow After Leases
380.22775.93265.65305.851,043274.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
395.58354.24642.78640.21520.63359.93
Change in Working Capital
192.81192.81-186.88-430.84427.52-75.91